Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy
- 18 December 2003
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 72 (2) , 181-186
- https://doi.org/10.1002/jmv.10580
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment responseAIDS, 2003
- Virological and immunological effects of salvage therapy following treatment interruption and a shift in HIV-1 resistance genotypeJournal of Medical Virology, 2002
- Immunologic and Virologic Consequences of Temporary Antiretroviral Treatment Interruption in Clinical PracticeAIDS Research and Human Retroviruses, 2002
- Evolution of Human Immunodeficiency Virus Type 1 Populations after Resumption of Therapy following Treatment Interruption and Shift in Resistance GenotypeThe Journal of Infectious Diseases, 2002
- Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable ViremiaNew England Journal of Medicine, 2001
- Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failureAIDS, 2000
- Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimenAIDS, 2000
- Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug ReactionsAnnals of Internal Medicine, 1999
- HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapyAIDS, 1999